{"id":"W4415940560","doi":"10.1016/j.annonc.2025.08.1739","title":"1101P FIRST/ENGOT-OV44 trial: Does the addition of dostarlimab (dost) impact niraparib (nira) tolerability, exposure, or dose modification?","year":2025,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Bevacizumab; Ovarian cancer; Chemotherapy; Platelet; Cyclophosphamide","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002280802,0.0006351792,0.002520991,0.0002024023,0.0002632481,0.001356834,0.0006486622,0.00138347,0.009837884],"category_scores_gemma":[0.00194895,0.0003407476,0.00242204,0.0002986889,0.0006803715,0.001305218,0.0003052927,0.004130362,0.001539898],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007696955,"about_ca_system_score_gemma":0.001001013,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006978213,"about_ca_topic_score_gemma":0.002856578,"domain_scores_codex":[0.9993024,0.0004012264,0.00003346713,0.00008339686,0.00004966541,0.0001298175],"domain_scores_gemma":[0.9993426,0.0002422017,0.0001238898,0.000066521,0.00003305065,0.0001917514],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7771736,0.003089355,0.002913393,0.001986025,0.004741219,0.00009710768,0.0001182776,0.001716709,0.004979262,0.001805892,0.01756865,0.1838105],"study_design_scores_gemma":[0.8771015,0.0733764,0.01530384,0.0006319021,0.004354467,0.0002020058,0.00009122637,0.002349925,0.001502076,0.003818542,0.0211871,0.00008103649],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9055361,0.03574781,0.001649047,0.01472538,0.002924713,0.001662313,0.006826396,0.0005075008,0.03042075],"genre_scores_gemma":[0.9710481,0.006770389,0.001748681,0.006993683,0.001093707,0.0007490085,0.003041899,0.0001055595,0.008449026],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.009837884,"threshold_uncertainty_score":0.03291106,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1533778700186327,"score_gpt":0.4850221905750722,"score_spread":0.3316443205564395,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}